STOCK TITAN

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Artivion, Inc. (NYSE: AORT) will release its first quarter 2024 financial results on May 6, 2024, followed by a teleconference call and webcast hosted by Pat Mackin, the Chairman, President, and CEO. Investors can access the live event by dialing 201-689-8261 or visiting the company's website. The earnings press release with financial and statistical information will be available on the Artivion website for further details.
Artivion, Inc. (NYSE: AORT) pubblicherà i risultati finanziari del primo trimestre del 2024 il 6 maggio 2024, seguiti da una teleconferenza e webcast presentati da Pat Mackin, Presidente e CEO dell'azienda. Gli investitori potranno partecipare all'evento in diretta chiamando il numero 201-689-8261 o visitando il sito web dell'azienda. Il comunicato stampa sui guadagni, contenente informazioni finanziarie e statistiche, sarà disponibile sul sito di Artivion per ulteriori dettagli.
Artivion, Inc. (NYSE: AORT) publicará sus resultados financieros del primer trimestre de 2024 el 6 de mayo de 2024, seguidos de una llamada de teleconferencia y transmisión web dirigida por Pat Mackin, el Presidente y CEO de la compañía. Los inversores podrán acceder al evento en vivo marcando el 201-689-8261 o visitando la página web de la empresa. El comunicado de prensa de ganancias con información financiera y estadística estará disponible en la página web de Artivion para más detalles.
아티비온, 인크 (NYSE: AORT)는 2024년 5월 6일에 2024년 첫 번째 분기 재무 결과를 발표하며, 이어서 Pat Mackin 회장 겸 CEO가 주관하는 전화 회의 및 웹캐스트가 진행될 예정입니다. 투자자들은 201-689-8261로 전화하거나 회사 웹사이트를 방문함으로써 생방송 이벤트에 참여할 수 있습니다. 재무 및 통계 정보가 포함된 수익 보도 자료는 Artivion 웹사이트에서 자세한 내용을 확인할 수 있습니다.
Artivion, Inc. (NYSE: AORT) publiera ses résultats financiers pour le premier trimestre de 2024 le 6 mai 2024, suivis par une téléconférence et une webdiffusion animées par Pat Mackin, le président et directeur général. Les investisseurs pourront accéder à l'événement en direct en composant le 201-689-8261 ou en visitant le site web de l'entreprise. Le communiqué de presse sur les résultats, contenant des informations financières et statistiques, sera disponible sur le site web d'Artivion pour plus de détails.
Artivion, Inc. (NYSE: AORT) wird am 6. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 veröffentlichen, gefolgt von einem Telekonferenzanruf und Webcast, geleitet von Pat Mackin, dem Vorsitzenden, Präsidenten und CEO. Investoren können das Live-Ereignis verfolgen, indem sie die Nummer 201-689-8261 wählen oder die Unternehmenswebsite besuchen. Die Pressemitteilung zu den Ergebnissen mit Finanz- und Statistikinformationen wird auf der Artivion-Website für weitere Details verfügbar sein.
Positive
  • None.
Negative
  • None.

ATLANTA, April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13744600. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion

Lance A. Berry

Executive Vice President &
Chief Financial Officer
Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Laine Morgan
Phone: 332-895-3222

investors@artivion.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2024-financial-results-302123717.html

SOURCE Artivion

FAQ

When will Artivion release its first quarter 2024 financial results?

Artivion will release its first quarter 2024 financial results on May 6, 2024.

Who will host the teleconference call and webcast for Artivion's first quarter 2024 financial results?

Pat Mackin, the Chairman, President, and CEO of Artivion, will host the teleconference call and webcast.

How can investors access the live teleconference for Artivion's financial results?

Investors can access the live teleconference by dialing 201-689-8261 a few minutes prior to 4:30 p.m. ET on May 6, 2024.

Where can investors find the earnings press release with financial and statistical information for Artivion's first quarter 2024 results?

Investors can find the earnings press release on the Investors section of the Artivion website.

What is the conference number for the teleconference replay of Artivion's first quarter 2024 financial results?

The conference number for the replay is 13744600.

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Stock Data

1.17B
36.71M
5.51%
87.55%
7.67%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
KENNESAW